Clinical Trial

Chronic Lung Allograft Dysfunction MRI Study

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-06; most recent amendment 2025-03-24.
Status change: Not Yet Recruiting → Recruiting 2025-03-24
Trial Details
NCT Number NCT06406777
Lead Sponsor Sean Fain
Conditions Chronic Lung Allograft Dysfunction Lung MRI (CLAD)
Enrollment 100 participants
Start Date 2025-03-20
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-06